loader
Please Wait
Applying Filters...

AbbVie Header AbbVie Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Active Pharmaceutical Ingredients (APIs) supplied/manufactured by Anhui Ribobay Pharmaceutical Co.,ltd

    Client Virtual Booth
    Menu

    Anhui Ribobay Pharmaceutical Co.,Ltd

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    SERVICES

    Key Services KEY SERVICES

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Givosiran (1)

    02 Inclisiran (1)

    03 Inotersen Sodium (1)

    04 Nusinersen (1)

    05 Patisiran (1)

    06 Viltolarsen (1)

    07 Volanesorsen Sodium (1)

    filter

    01 Anhui Ribobay Pharmaceutical Co.,Ltd (7)

    filter

    01 China (7)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual BoothRibobay has years of experience in oligonucleotides ranging from siRNA, microRNAs, & aptamers, as well as oligonucleotides CXO.
      Contact Supplier Contact Supplier
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Givosiran

      PDF Supplier PDF
      URL Supplier Web Content
      Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol...
      Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.
      Ribobay-Company-Banner

      20th Annual OTS

      Attending

      envelop Contact Supplier

      Contact Supplier
        Virtual BoothRibobay has years of experience in oligonucleotides ranging from siRNA, microRNAs, & aptamers, as well as oligonucleotides CXO.
        Contact Supplier Contact Supplier
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Inclisiran

        PDF Supplier PDF
        URL Supplier Web Content
        Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol...
        Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.
        Ribobay-Company-Banner

        20th Annual OTS

        Attending

        envelop Contact Supplier

        Contact Supplier
          Virtual BoothRibobay has years of experience in oligonucleotides ranging from siRNA, microRNAs, & aptamers, as well as oligonucleotides CXO.
          Contact Supplier Contact Supplier
          Flag China
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Inotersen Sodium

          PDF Supplier PDF
          URL Supplier Web Content
          Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol...
          Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.
          Ribobay-Company-Banner

          20th Annual OTS

          Attending

          envelop Contact Supplier

          Contact Supplier
            Virtual BoothRibobay has years of experience in oligonucleotides ranging from siRNA, microRNAs, & aptamers, as well as oligonucleotides CXO.
            Contact Supplier Contact Supplier
            Flag China
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            Nusinersen

            PDF Supplier PDF
            URL Supplier Web Content
            Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol...
            Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.
            Ribobay-Company-Banner

            20th Annual OTS

            Attending

            envelop Contact Supplier

            Contact Supplier
              Virtual BoothRibobay has years of experience in oligonucleotides ranging from siRNA, microRNAs, & aptamers, as well as oligonucleotides CXO.
              Contact Supplier Contact Supplier
              Flag China
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Patisiran

              PDF Supplier PDF
              URL Supplier Web Content
              Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol...
              Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.
              Ribobay-Company-Banner

              20th Annual OTS

              Attending

              envelop Contact Supplier

              Contact Supplier
                Virtual BoothRibobay has years of experience in oligonucleotides ranging from siRNA, microRNAs, & aptamers, as well as oligonucleotides CXO.
                Contact Supplier Contact Supplier
                Flag China
                Virtual Booth Virtual Booth
                Digital Content Digital Content

                Viltolarsen

                PDF Supplier PDF
                URL Supplier Web Content
                Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol...
                Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.
                Ribobay-Company-Banner

                20th Annual OTS

                Attending

                envelop Contact Supplier

                Contact Supplier
                  Virtual BoothRibobay has years of experience in oligonucleotides ranging from siRNA, microRNAs, & aptamers, as well as oligonucleotides CXO.
                  Contact Supplier Contact Supplier
                  Flag China
                  Virtual Booth Virtual Booth
                  Digital Content Digital Content

                  Volanesorsen Sodium

                  PDF Supplier PDF
                  URL Supplier Web Content
                  Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol...
                  Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.
                  Ribobay-Company-Banner

                  20th Annual OTS

                  Attending

                  envelop Contact Supplier

                  Post Enquiry
                  POST ENQUIRY